These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4971577)

  • 41. Serotonin and behavioral inhibition.
    Stein L; Wise CD
    Adv Biochem Psychopharmacol; 1974; 11(0):281-91. PubMed ID: 4276861
    [No Abstract]   [Full Text] [Related]  

  • 42. Behavioral sensitivity to LSD: dependency upon the pattern of central 5HT depletion.
    Joseph JA; Appel JB
    Pharmacol Biochem Behav; 1977 May; 6(5):499-504. PubMed ID: 142991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the brain with drugs.
    Marrazzi AS
    Cond Reflex; 1968; 3(3):181-8. PubMed ID: 4387187
    [No Abstract]   [Full Text] [Related]  

  • 44. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
    Schoenfeld RI
    Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of anticholinergic drugs, chlorpromazine and LSD-25 on evoked potentials, EEG and behaviour.
    Green DM; Aldous FA
    Prog Brain Res; 1972; 36():143-58. PubMed ID: 4644024
    [No Abstract]   [Full Text] [Related]  

  • 46. Environmental influences upon drug-induced suppression of operant behavior.
    Sparber SB; Tilson HA
    J Pharmacol Exp Ther; 1971 Oct; 179(1):1-9. PubMed ID: 5096565
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat.
    Ruffing DM; Domino EF
    Psychopharmacology (Berl); 1981; 75(3):226-30. PubMed ID: 6798611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Facilitation of avoidance behaviour by LSD-25 and mescaline in hamsters.
    Sansone M; Castellano C; Messeri P
    Pharmacol Res Commun; 1974 Aug; 6(4):369-76. PubMed ID: 4438404
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on the specificity of neurochemical and behavioral effects of LSD-25.
    Sparber SB; Dwoskin LP; Kleven MS
    Pharmacol Biochem Behav; 1986 Feb; 24(2):341-5. PubMed ID: 3952124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 51. A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD).
    Hirschhorn ID; Rosecrans JA
    Pharmacol Biochem Behav; 1974 May; 2(3):361-6. PubMed ID: 4837907
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of conflict upon schedule-induced consumption of water and alcohol.
    Freed EX
    Psychol Rep; 1971 Aug; 29(1):115-8. PubMed ID: 5093039
    [No Abstract]   [Full Text] [Related]  

  • 53. Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment.
    Wang RY; Aghajanian GK
    Commun Psychopharmacol; 1980; 4(1):83-90. PubMed ID: 7398246
    [No Abstract]   [Full Text] [Related]  

  • 54. Antidepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule.
    Kinney GG; Griffith JC; Hudzik TJ
    Behav Pharmacol; 1998 Jul; 9(4):309-18. PubMed ID: 10065919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LSD, psychotogenic procedures, and brain neurohumors.
    Freedman DX
    Psychopharmacol Bull; 1975 Apr; 11(2):42-3. PubMed ID: 237298
    [No Abstract]   [Full Text] [Related]  

  • 56. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gross behavioural changes in monkeys following administration of LSD-25, and development of tolerance to LSD-25.
    Jonas S; Downer Jde C
    Psychopharmacologia; 1964 Oct; 6(4):303-6. PubMed ID: 4953438
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of reinforcement omission on rats with lesions in the amygdala.
    Henke PG
    J Comp Physiol Psychol; 1973 Jul; 84(1):187-93. PubMed ID: 4577766
    [No Abstract]   [Full Text] [Related]  

  • 59. Evidence for antiserotonergic properties of yohimbine.
    Dwoskin LP; Neal BS; Sparber SB
    Pharmacol Biochem Behav; 1988 Oct; 31(2):321-6. PubMed ID: 3244710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.